Company profile
株式会社永冨調剤薬局· Corporate Number: 3320001002010
This page aggregates company identity, Official Gazette notices, enforcement records, related-company signals, and source-review links into one public-record profile.
RegBase Evidence Report
Company identity, confirmed enforcement records, Official Gazette notices, and source-review fields for internal due-diligence files.
| Display name | 株式会社永冨調剤薬局 | Original name | 株式会社永冨調剤薬局 |
|---|---|---|---|
| Corporate Number | 3320001002010 | Status | Unknown |
| Confirmed enforcement | 0 record(s) | Official Gazette | 1 notice(s) |
| Registry changes | 0 item(s) | Related companies | 0 candidate(s) |
| Latest public record | 21 Jun 2024 | ||
This report summarizes public-source records collected by RegBase. It is not a credit opinion, sanctions result, legal conclusion, or procurement approval. Verify material findings against the linked original Japanese source before relying on them.
| English display | 株式会社永冨調剤薬局 (Japanese original) |
|---|---|
| Japanese name | 株式会社永冨調剤薬局 |
| Address | 大分県大分市下郡北１丁目４番４５号 |
| Representative | Not recorded |
| Industry | Not recorded |
| Official website | Not recorded |
| Target URL | https://regbase.jp/en/company/403cb678-a1ca-43c8-a3c7-c01d25b57d3f |
|---|---|
| Regulatory enforcement disclosures | No confirmed linked record in RegBase monitored coverage |
| Official Gazette notices | 1 notice(s) linked in RegBase coverage |
| Registry-source timestamps | Corporate Number site: 14 May 2026 / gBizINFO: not recorded / EDINET: not recorded |
No confirmed enforcement record is currently linked to this company in RegBase monitored sources.
| Citation | 21 Jun 2024 Extra Edition 第149号 p.135 |
|---|---|
| Published name | 株式会社永冨調剤薬局 |
| Address / court | 21日金曜日 官 報 （号 外） 公 告 会社その他の公告 第42期決算公告 令和6年6月 21 日 大分県大分市下郡北一丁目4番45号 |
| Excerpt | This is a financial statements notice for the 42nd fiscal year, ending March 31, 2024, including a balance sheet summary. |
| Original sources checked | |
|---|---|
| Reviewer / date | |
| Internal notes |
Current page: Company profile
This page brings together Official Gazette notices, enforcement records, registry data, related-company signals, and source-review links for one company. Open individual enforcement records from the history section below.
Free report
Includes company identity, enforcement history, Official Gazette notices, source-review fields, and reviewer notes for internal due-diligence files.
Related tool Kiroku
Open Kiroku monitoring and enter the official website, terms, IR, pricing, or announcement URL you want to track.
You do not need this for normal browsing. Use it when integrating this company record into an internal tool or AI workflow.
Note: Detailed gBizINFO registry data may not be available for this company yet. Use the public registry links below to review supplemental source information.
Corporate Number site: fetched 14 May 2026
Official Gazette
Notice of Financial Statements for the 42nd Fiscal Year
Financial statements noticeFinancial disclosure号外第 １４９ 号 令和６年６月２１日金曜日 官 報 （号 外） 公 告 会社その他の公告page="0135"page="0135" 第42期決算公告 令和６年６月 21 日 大分県大分市下郡北一丁目４番45号株式会社永冨調剤薬局代表取締役 永冨 茂page="0135"貸借対照表の要旨 (令和６年３月31日現在) (単位：千円)科 目金 額 科 目金 額 流動資産2,336,773流動負債530,284固定資産296,259(賞与引当金)(50,380)固定負債231,565(退職給付引当金)(74,128)役員退職慰労引当金 (150,897)株主資本1,870,450資本金30,000利益剰余金1,840,450利益準備金7,500その他利益剰余金1,832,950(うち当期純利益)(172,857)評価・換算差額等732 資産合計 2,633,032負債・純資産合計2,633,032©2010独立行政法人国立印刷局/National Printing Bureau. All rights reserved.
No enforcement records are currently listed in RegBase's monitored sources.
RegBase automatically collects public disclosures from Japanese government sources. Non-public administrative guidance, oral warnings, and unpublished actions are not included. See data sources.
About this English name
No official English name source is recorded. The original Japanese name is shown.
If this profile contains an error or your company needs to add context, please use the correction request form. Submissions are reviewed under RegBase editorial policy.
This page mechanically aggregates and structures public government disclosures and public registry data under the editorial policy. It is not legal advice, credit scoring, or a final procurement decision. Always verify against the official source pages.